For example, BRCA1 mutations in breast and pancreatic cancer are associated with increased density of tumor-associated macrophages (TAMs) and T cells, as compared to wildtype tumors and BRCA2 mutant tumors [110,112]. This evidence concerns the gene BRCA2 and pancreatic neoplasm.